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AIM: To estimate the incidence of intracranial tumors in the adult population of the Varaždin 
County, Croatia, for the 1996-2004 period. 
METHODS: Setting: Varaždin County General Hospital and four university hospitals in Zagreb, 
the capital of Croatia. Study period: January 1,1996 to December 31, 2004. Incident patients: 
county residents admitted for newly diagnosed intracranial tumors according to the WHO 
diagnostic criteria. Demographic data were extracted from the 2001 Croatian census. Incidence 
rates (IR) per 100000 person-years (p-y) and annual IRs (per 100000 persons) were determined 
and compared as incidence rate ratios (IRR) with 95% CI. 
RESULTS: For primary intracranial tumors (PIT), IR was 12.1/100000 p-y (95% CI 10.3 to 
14.2), comparable in men and women. The highest incidence was recorded for glioblastoma (IR 
4.8, 3.7 to 6.2) and meningioma (IR 3.1, 2.2 to 4.2). The incidence of PIT was somewhat greater 
than that of metastatic tumors (IRR 1.58, 95% CI 1.22 to 2.05, p<0.001). Metastatic tumors were 
more frequent in men than in women, especially metastatic lung tumors (IRR 6.08, 2.32 to 20.16, 
p<0.001). IRs of all PIT taken together, neuroepithelial tumors cumulatively, non-epithelial 
tumors cumulatively, glioblastoma and meningioma were higher in the population aged ≥40 vs. 
population aged ≤39 (all IRRs with 95% CI greater than 1, p<0.05 or <0.001), comparable in 
men and women. Women were somewhat older than men at the time of diagnosis of PIT: median 
difference -6 years (95.1% CI -10 to -1, p<0.05). Annual IRs for all these tumor categories 
showed increasing trends over the study period.  
CONCLUSION: Overall, there was an increasing trend in the incidence of primary intracranial 
tumors in the Varaždin County. Data did not allow estimation for most of the specific tumor 
types.  
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Introduction 
Intracranial tumors bear unfavorable clinical prognosis merely by their localization. Primary 
intracranial tumors arise from intracranial cell mutagenesis, triggers of which are largely 
unknown. The most common primary intracranial tumors in adults are those of neuroepithelial 
origin. Regarding specific tumor types, the most frequent are gliomas, followed by meningiomas 
and pituitary gland tumors [1-4]. Men appear to be at an increased risk of developing gliomas as 
compared to women, whereas the risk of developing meningioma appears to be lower in men [1]. 
Secondary or metastatic intracranial tumors may originate from different sites. Of “peripheral” 
tumors, lung cancer (carcinoma bronchii) is the most likely one to spread intracranially, 
followed by breast carcinoma [9]. Metastatic intracranial tumors are more frequent in men than 
in women due to the higher incidence of lung cancer in men [9]. 
Epidemiological studies have indicated a steady increase in incidence rates of intracranial tumors 
over the last few decades in both sexes and in all age groups [3,6-9], although there has been 
some debate about whether the increasing trends are true or artifactual [10]. Unlike many other 
countries [4,7,11,12,13,14,15], epidemiological data on intracranial tumors in the adult 
population in Croatia have been rather incomplete since the early 1990s – there are some 
regional reports [16], and the existing Croatian Cancer Registry [17] is not consistently updated 
[16]. We aimed to assess regional epidemiological data on intracranial tumors in the adult 
population of the Varaždin County. We believe this would help in establishing the grounds for 
future observational studies that would, eventually, contribute to regaining a proper insight into 
the epidemiology of intracranial tumors at the national level.  
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Subjects and Methods 
Study design 
This was a retrospective population-based incidence study. Incident patients (“cases”) were 
defined as adult (≥18 years of age) Varaždin County residents with newly diagnosed intracranial 
tumors according to the WHO diganostic criteria [1] during the period between January 1, 1996 
and December 31, 2004. All “cases” were embraced with MRI or CT imaging. Demographic 
data on the Varaždin County population were extracted from the Croatian 2001 census [18]. 
Varaždin County population 
Varaždin County is located in the outermost northwestern part of Croatia. With 1261.29 km² it is 
one of the smallest Croatian counties. According to the 2001 census, the Varaždin County 
population was 184769, 84839 (48.6%) men and 94930 (51.4%) women, accounting for 4.2% of 
the total Croatian population. The Varaždin County adult population (≥18 years of age) was 
144634, 69488 (48.0%) men and 75498 (52.0%) women. The population density of 146.6 
inhabitants/km² makes it one of the most populous counties in Croatia. The population is located 
in 6 towns (the largest one and the County capital is Varaždin) and 22 communities. 
Approximately 55% of the inhabitants live in urban and 45% in rural parts of the County. The 
total number of inhabitants increased by only about 5000 over a 30-year period (1971-2001), 
indicating a stability in demographic variation [18]. 
Varaždin County economy and healthcare system 
The economy is based on textile and food industry, agriculture, hunt and forestry, architecture 
and building and distribution companies. The healthcare system consists of 101 primary 
healthcare teams organized through 4 medical centers (Varaždin, Ludbreg, Ivanec and Novi 
Marof), County Public Health Institute, Varaždin County General Hospital, 3 special hospitals 
(Klenovnik, Novi Marof and Varaždinske Toplice), and several private institutions. During the 
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study period, there were two CT units and no MRI units in the Varaždin County. The Varaždin 
County inhabitants commonly seek medical services in the capital (Zagreb) due to its proximity.  
Data collection 
Varaždin County General Hospital is the only medical institution in the County equipped for the 
diagnosis and treatment of malignant diseases. However, not to miss potential “cases” that have 
not been, at any instance, admitted to the County hospital, we searched not only the central 
database at the hospital but also databases at the main institutions in Zagreb that deal with 
intracranical tumors and malignant diseases in general: Zagreb University Hospital Center, Sestre 
milosrdnice University Hospital, Jordanovac University Hospital for Pulmonary Diseases, and 
Dubrava University Hospital. Every effort was made to obtain all valuable information. Incident 
patients were identified, assigned identification codes, and data on their demographics, date and 
age of the tumor diagnosis and tumor type (pathohistologic diagnosis) were retrieved. 
For primary intracranial tumors (n=158), pathohistologic confirmation was established in 133 
(84%) patients, a rate comparable to “pathohistologic confirmation” rates reported from other 
studies in different countries, e.g., Switzerland (75% to 95%), Canada (27% to 91%), Brazil 
(45% to 87%) and United States (63% to 99%) [19]. The pathohistologic confirmation for 
presumed secondary intracranial masses was around 45%. For secondary tumors without a 
pathohistologic diagnosis we reviewed neuroradiologic reports (available in all cases). When the 
images showed multiple intracranial tumors remote from the dura that were accompanied by 
clinical information on a systemic malignant disease, we considered the lesions as metastatic 
tumors [13]. 
Determination of incidence rates 
Considering the reported stability of the total number of inhabitants in the Varaždin County 
between 1971 and 2001, we used the 2001 census data as a basis for calculation of incidence 
rates [18]. Since the study was focused on adult patients, i.e., patients aged ≥18, the demographic 
 6 
basis was 144634 inhabitants, 69488 men and 75498 women [18]. All incidence rates referring to 
the entire study period (1996-2004) were determined per 100000 person-years (p-y). Annual 
incidence rates were determined per 100000 inhabitants. 
Data handling and statistical analysis 
Database was built using Microsoft Access version 2000 (Microsoft Inc., Seattle, WA, USA). 
Summary statistics is reported on sex and age at diagnosis for the incident patients. Difference in 
the age at diagnosis between men and women was determined as a median difference with 95.1% 
approximate confidence intervals (CI), and statistical significance was tested using the Mann-
Whitney U-test. Incidence rates (IR) and all other epidemiologic indices are reported with the 
Poisson-based 95% CI. Difference between two incidence rates is given as an incidence rate ratio 
(IRR) employing the conditional maximum likelihood estimation and exact confidence intervals. 
Annual incidence rate curves were shown as “true” IRs and smoothed curves, using the “rolling 
average” approach. Rolling four-year medians of incident patients were calculated and expressed 
as IR per 100000 persons (four-year rolling average IR). We used StatsDirect version 2.3.8 




Total and sex- and age-specific incidence according to tumor type 
For the period between January 1, 1996 and December 31, 2004, we identified a total of 264 
Varaždin County residents aged ≥18 with newly diagnosed intracranial tumors (incident 
patients), yielding an incidence rate of 20.3/100000 p-y. Table 1 presents the number of incident 
patients according to tumor type and sex, and Table 2 shows corresponding incidence rates and 
menwomen incidence rate ratios. There were more incident men than women, yielding an IR 
greater by 38% in men (95% CI for IRR 1.08 to 1.78; p=0.01) (Table 2). The incidence rate of 
primary intracranial tumors (158 cases, IR=12.1/100000 p-y) was higher than the incidence rate 
of metastatic tumors (99 cases, IR=7.6/100000 p-y); IRR=1.58, 95% CI 1.22 to 2.05, p<0.001. 
The incidence of metastatic intracranial tumors was by 152% higher in men than in women 
(p<0.001): by 508% higher in case of metastatic lung tumors (p<0.001) and by 90% higher for 
tumors of other origin (p=0.013) (Table 2). According to the origin, primary intracranial tumors 
were more frequently neuroepithelial (87 cases, IR=6.7/100000 p-y) than nonepithelial (71 cases, 
IR=5.5/100000 p-y) (Tables 1 and 2) – IRR=1.23 (95% CI 0.89 to 1.70). There appeared to be no 
major sex difference in the incidence of primary intracranial tumors, either neuroepithelial or 
nonepithelial (Table 2). According to histologic type, glioblastoma showed highest incidence 
among primary intracranial tumors (63 cases, IR=4.8/100000 p-y), which was comparable in 
men and women (Tables 1 and 2), followed by meningioma (40 cases, IR 3.1/100000 p-y) which, 
however, showed a higher incidence (by 28%) in women than in men (Tables 1 and 2). Other 
tumor types with IRs >0.2/100000 p-y were pituitary adenoma (IR=0.8), schwannoma (IR=0.6), 
anaplastic astrocytoma (IR=0.5), and astrocytoma, ependymoma, primary malignant lymphoma 
and anaplastic oligodendroglioma, IR 0.3 each (Tables 1 and 2). 
Except for glioblastoma and meningioma, the incidence of specific primary intracranial tumor 
types was too low for evaluation of age-specific incidence rates. The overall incidence rate of 
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primary intracranial tumors, of neuroepithelial tumors cumulatively, of nonepithelial tumors 
cumulatively, and of glioblastoma and meningioma all showed a similar rising pattern in older 
age groups, peaking in the 60-69 or 70-79 age groups (Figure 1). For all these “tumor categories” 
IRs were clearly higher in the population aged ≥40 as compared with the population aged ≤39 
(Figure 2). In both age groups, IRs of all “tumor categories” were comparable between men and 
women, although there was a trend of higher IR of neuroepithelial tumors in men vs. women in 
the ≤39 age group (IRR 4.21, 95% CI 0.89 to 40.07), and a trend of lower IR of nonepithelial 
tumors in men vs. women in the ≥40 age group (IRR 0.76, 95% CI 0.44 to 1.30) (Figure 2). 
Generally, women were somewhat older than men at the time of diagnosis for all main “tumor 
categories” (Table 3). 
Annual incidence of primary intracranial tumors – total and sex-specific 
When all primary intracranial tumors were considered cumulatively, annual IRs (per 100000 
population) were rather variable between 1996 and 2004 (Figure 3). However, smoothed (rolling 
average) curves indicated an increasing trend from 1999 towards 2004, for both men and women 
(Figure 3). A very similar pattern was observed for neuroepithelial tumors cumulatively 
(increasing trend somewhat more prominent in men) and for nonepithelial tumors cumulatively 
(increasing trend somewhat more prominent in women) (Figure 3). There appeared to be no 




Epidemiologic data on intracranial tumors in the adult Croatian population have been rather 
incomplete since the early 1990s [16]. The present study attempted to estimate the incidence of 
intracranial tumors in the adult population in one of the Croatian counties (Varaždin County) for 
the period between 1996 and 2004. The obvious limitation of the study was its retrospective 
design and the fact that it was based on hospital database searches. Consequently, it is possible 
that the results were confounded by underreporting, i.e., missed “cases”. However, we believe 
that the reported rates are fairly accurate since the search for incident patients included all 
relevant institutions to which the County population are referred, i.e. Varaždin County General 
Hospital, which is the only institution in the County equipped for the diagnosis and treatment of 
malignant diseases, and four university hospitals in the nearby state capital Zagreb. The fact that 
the observed incidence rate of primary intracranial tumors (12.1/100000 person-years) was 
comparable to that reported for the whole Croatia in 1991 (11.7/100000 person-years) [17], when 
the central Croatian Registry was still functioning, supports the validity of the current 
observations. Also, this incidence rate does not appear to differ much from that reported from the 
United States Central Brain Tumor Registry for the similar time period (1997-2001) 
(14.1/100000 person-years) [12]. As expected [1-4], glioblastoma was a primary intracranial 
tumor of the highest incidence, followed by meningioma and pituitary adenoma. However, 
except for glioblastoma and meningioma, the incidence rates of particular tumor types were very 
low. Therefore, the analysis was restricted to a few “tumor categories”, i.e. primary intracranial 
tumors overall, neuroepithelial tumors cumulatively, nonepithelial tumors cumulatively, 
glioblastoma and meningioma. Several of the present observations regarding primary intracranial 
tumors are in agreement with those reported by others: there was an increasing trend in the 
overall incidence of primary intracranial tumors, both neuroepithelial and nonepithelial (although 
this was not obvious for glioblastoma or meningioma) [3,6-9]. The incidence rates of all “tumor 
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categories” analyzed tended to increase with age [4,12,20], and the incidence rate of meningioma 
tended to be greater in women than in men [3,5,12]. On the other hand, the incidence rates of 
neuroepithelial tumors (cumulatively) appeared to be comparable for men and women, whereas a 
higher incidence in men has been reported elsewhere [3,5,12]. Also, women appeared to be at an 
older age at the time of diagnosis than men, whereas some studies report opposite findings [13]. 
Overall, however, the present data do not seem to deviate much from other respective literature 
reports. 
In the present study, the incidence rate of metastatic tumors appeared to be somewhat lower than 
that reported for Croatia in 1991 [17] (7.6 vs. 9.4/100000 person-years). This discrepancy might 
have been due to underreporting of metastatic intracranial tumors, which is a common 
phenomenon and might be due to a variety of reasons [21]. The incidence rate of metastatic 
tumors was clearly much higher in men than in women. This was most likely due to a great 
difference in the incidence of lung carcinoma between Croatian men and women, a phenomenon 
related to the higher prevalence of smokers among men [17]. 
In conclusion, we conducted a retrospective incidence study to assess the regional epidemiologic 
data on intracranial tumors in the adult population in one of the Croatian counties (Varaždin 
County) for the 1996-2004 period. Considering primary intracranial tumors, the present data do 
not seem to deviate much from the similar literature reports. Since the epidemiologic data on 
intracranial tumors in Croatia have been rather incomplete, we believe that this effort would help 
in establishing the grounds for future observational studies that would, eventually, contribute to 
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Table 1. Number of patients with intracranial tumors in the Varaždin County population aged 
≥18 (total 144634, 69488 men, 75409 women, see Patients and Methods) for the 1996-2000 
period 
 
Tumor type Men Women Total (%)* 
Primary intracranial 73 85 158 (100.0)* 
Neuroepithelial 44 43 87 (55.1) 
Other primary 29 42 71 (44.9) 
By histology    
Glioblastoma  32 31 63 (39.9) 
Meningioma 16 24 40 (25.3) 
Pituitary adenoma 7 4 11 (7.0) 
Schwannoma 2 6 8 (5.1) 
Anaplastic astrocytoma  4 3 7 (4.4) 
Astrocytoma  2 2 4 (2.5) 
Ependymoma  2 2 4 (2.5) 
Primary malignant lymphoma 1 3 4 (2.5) 
Anaplastic oligodendroglioma  3 1 4 (2.5) 
Oligodendroglioma  0 3 3 (1.9) 
Craniopharyngioma  1 2 3 (1.9) 
Anaplastic oligoastrocytoma  1 1 2 (1.3) 
Anaplastic ganglioglioma 1 0 1 (0.6) 
Medulloblastoma 1 0 1 (0.6) 
Hemangioblastoma 0 1 1 (0.6) 
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Anaplastic meningioma 1 0 1 (0.6) 
Pineal parenchymal tumors 0 1 1 (0.6) 
    
Metastatic 70 29 99 (100.0)* 
Lung tumors 28 5 33 (33.3) 
Other primary sites 42 24 66 (66.6) 
    
Cysts and tumor-like lesions 1 2 3* 
Unknown 4 0 4* 
Total 148 116 264 
*Percentage used different denominators: for primary tumors, the total number of these tumors was considered as 
100% and a breakdown by neuroepithelial origin (yes or no) and further histologic type is given. For metastatic 
tumors, the total number of such tumors was considered as 100%. Cysts and tumor-like lesions are not given in 




Table 2. Incidence rates (IR) per 100000 person-years and men/women rate ratios (IRR) (with 
95% CI) determined from data in Table 1 (only for tumors with at least 2 recorded “cases”) 
 









Primary intracranial 12.1 (10.3 to 14.2) 11.7 12.5 0.93 (0.67 to 1.29) 0.691 
Neuroepithelial 6.7 (5.4 to 8.2) 7.0 6.3 1.11 (0.71 to 1.73) 0.668 
Non-epithelial 5.5 (4.3 to 6.9) 4.6 6.2 0.75 (0.45 to 1.23) 0.238 
By histology      
Glioblastoma 4.8 (3.7 to 6.2) 5.1 4.6 1.12 (0.66 to 1.89) 0.706 
Meningioma 3.1 (2.2 to 4.2) 2.6 3.5 0.72 (0.36 to 1.42) 0.345 
Pituitary adenoma 0.8 (0.4 to 1.5) 1.1 0.6 1.9 (0.48 to 8.84) 0.372 
Schwannoma 0.6 (0.3 to 1.2) 0.3 0.9 0.36 (0.04 to 2.02) 0.292 
Anaplastic astrocytoma 0.5 (0.2 to 1.1) 0.6 0.4 1.45 (0.24 to 9.88) 0.717 
Astrocytoma 0.3 (0.08 to 0.8) 0.3 0.3 1.09 (0.08 to 14.97) 0.999 
Ependymoma 0.3 (0.08 to 0.8) 0.3 0.3 1.09 (0.08 to 14.97) 0.999 
Primary malignant lymphoma 0.3 (0.08 to 0.8) 0.2 0.4 0.36 (0.007 to 4.5) 0.626 
Anaplastic oligodendroglioma 0.3 (0.08 to 0.8) 0.5 0.1 3.26 (0.26 to 170) 0.356 
Oligodendroglioma 0.2 (0.05 to 0.7) 0 0.4 0 (0 to 2.26) 0.251 
Craniopharyngioma 0.2 (0.05 to 0.7) 0.2 0.3 0.52 (0.009 to 10.42) 0.999 
Anaplastic oligoastrocytoma 0.2 (0.02 to 0.6) 0.2 0.1 1.09 (0.01 to 85.19) 0.999 
      
Metastatic 7.6 (6.2 to 9.3) 11.2 4.3 2.62 (1.68 to 4.19) < 0.001 
Lung tumors 2.5 (1.7 to 3.6) 4.5 0.7 6.08 (2.32 to 20.16) < 0.001 
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Other primary sites 5.1 (3.9 to 6.5) 6.7 3.5 1.90 (1.12 to 3.18) 0.013 
Cysts and tumor-like lesions 0.2 (0.05 to 0.7) 0.2 0.3 0.52 (0.009 to 10.42) 0.999 
Unknown 0.3 (0.08 to 0.8) 0.6 0 infinity  








Table 3. Patient age (years) at diagnosis of intracranial tumors (by type) in the Varaždin County 
for the 1996-2004 period. Data are medians (quartiles). Median difference between men and 
women with 95.1% CI is given for the main tumor groups 
 
 Age at diagnosis Men-women 
 Men Women Total  
Primary intracranial 56 (46-65) 63 (49-69) 60 (48-68) -6 (-10 to -1)* 
Neuroepithelial 55.5 (43-66.5) 61 (48-71) 58 (47-69) -5 (-12 to 2) 
Nonepithelial 56 (48-61) 63 (55-67) 61 (50-67) -7 (-12 to -1)* 
By histology     
Glioblastoma 61.5 (52-68.5) 66 (49-72) 63 (50-71) -4 (-10 to 4) 
Meningioma 56.5 (48.5-63) 65 (61-69) 61 (55-67) -9 (-15 to -1)* 
Pituitary adenoma 55 (31-57) 59 (35.5-69.8) 55 (31-61)  
Schwannoma 64 (59-69) 65 (59.3-68.5) 65 (59.5-68-8)  
Anaplastic astrocytoma  49 (44-51) 66 (51-81) 51 (47-66)  
Astrocytoma  27 (24-30) 45.5 (43-48) 36.5 (25.5-46.8)  
Ependymoma  42 (28-56) 51 (48-54) 51 (33-55.5)  
Primary malignant lymphoma 66 62 (60-66) 64 (60.5-66)  
Anaplastic oligodendroglioma  68 (32-73) 36 52 (33-71.5)  
Oligodendroglioma  --- 61 (48-68) 61 (48-68)  
Craniopharyngioma  68 24.5 (22-27) 27 (22-68)  
Anaplastic oligoastrocytoma  26 43 34.5 (26-43)  
Anaplastic ganglioglioma 33 --- 33  
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Medulloblastoma 23 --- 23  
Hemangioblastoma 27 --- 27  
Anaplastic meningioma --- 55 55  
Pineal parenchymal tumors --- 44 44  
Metastatic 63 (57-69) 68 (59-70) 64 (57-69.5) -2 (-6 to 2) 
Lung tumors 63.5 (58-70.5) 70 (68-73) 64 (58-71) -6 (-16 to 3) 
Other primary sites 62.5 (55-68) 66.5 (55.5-69) 63.5 (55-69) -1.5 (-6 to 4) 
Cysts and tumor-like lesions 29 30 (25-35) 44  
Unknown 47.5 (36-58.3) --- 47.5 (36-58.3)  
Total 60 (50-68) 63 (50.5-69.8) 61 (50-69) -3 (-6 to 0)** 








Figure 1. Age-specific incidence rates (per 100000 person years) of primary intracranial tumors 
in the adult population (≥18 years of age) of the Varaždin County for the 1996-2004 period, 
overall and by sex. Except for glioblastoma and meningioma, data for specific tumor types are 










Figure 2. Differences in incidence rates of primary intracranial tumors according to age and sex, 
by “tumor category” (all primary, neuroepithelial cumulatively, nonepithelial cumulatively, 
glioblastoma, meningioma). Upper panel: incidence rate ratios (IRRs, 95% CI) for the 
population aged ≥40 (40+) vs. population aged ≤39, according to sex. IRR above 1 indicates 
higher IR in older population, and IR below 1 indicates higher IR in younger population. For all 
IRRs p values were <0.05 or <0.001. Lower panel: men/women IRRs according to age groups 










Figure 3. Annual incidence rates (per 100000 persons) of primary intracranical tumors in adult 
population (≥18 years of age) of the Varaždin County for the 1996-2004 period, overall and 
according to sex. Except for glioblastoma and meningioma, data for specific tumor types are not 
shown due to low incidence rates. Data are true (raw) incidence rates, and inserted boxes show 
“smoothed” (four-year rolling average) curves. 
 
